Taking on the hidden challenge of male-factor infertility

We are an Australian med-tech company building evidence-based tools for sperm identification and isolation in the IVF lab.

Milestones

  1. 2023SpermGuide pre-clinical study published in Microsystems & Nanoengineering
  2. 2024SpermSearch.AI pre-clinical study published in Reproductive BioMedicine Online
  3. 2025SpermGuide paper named runner-up for the Robert G. Edwards Prize Paper
  4. 2026SpermSearch.AI included in the ARTG and UKCA marked, and its clinical study published

Our mission

For too many couples, male-factor infertility remains a hidden challenge to starting a family. We develop biologically-inspired technologies that give IVF laboratories faster tools, with one simple goal: to help more couples have a child of their own.

Leading minds across science, engineering and design

  • Embryology
  • Reproductive medicine
  • Machine learning
  • Microfluidics
  • Product design
  • Commercialisation

The people behind NeoGenix

Leadership

  • Portrait of Steven Vasilescu

    Steven Vasilescu, Ph.D

    Co-founder & CEO

  • Portrait of Dale Goss

    Dale Goss

    CSO & Clinical Embryologist

  • Portrait of Saeed Fathi

    Saeed Fathi, Ph.D

    Fractional CTO

Technical team

  • Portrait of Benny Dai

    Benny Dai, Ph.D

    Software Development Lead

  • Portrait of Phillip Vasilescu

    Phillip Vasilescu

    Senior Software Developer

  • Portrait of Jack Tochner

    Jack Tochner

    Machine Learning Engineer

Advisors

  • Portrait of Prof. David K. Gardner

    Prof. David K. Gardner, AM, FAA

    Clinical Strategy and Advisor

  • Portrait of Gavin Sacks

    Gavin Sacks, MA BM DPhil FRCOG FRANZCOG

    Clinical Advisor

  • Portrait of Majid Warkiani

    Majid Warkiani, Ph.D

    Advisor & Co-Founder

Our collaborators

  • Virtus Health logo
  • University of Technology Sydney logo
  • Maze Men's Sexual and Reproductive Health logo
  • Medical Angels logo
  • Australian National Fabrication Facility logo
  • Avenues logo

Build the future of fertility care with us